The reported statements, read against the company's own industry.
Financials view
Market Capitalization
709.97MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Revenue (TTM)
86.17MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Profit Margin
-93.86%
vs Health Information Services peers
Updated Sep 28, 2026
Beta
0.9820x
vs all stocks
Updated Sep 28, 2026
52-Week Change
93.00%
vs all stocks
Updated Sep 28, 2026
Market Capitalization
709.97MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Enterprise Value
664.13MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Forward P/E
-16.68x
vs Health Information Services peers
Updated Sep 28, 2026
Price to Sales (TTM)
8.24x
vs Health Information Services peers
Updated Sep 28, 2026
Price to Book (MRQ)
8.55x
vs Health Information Services peers
Updated Sep 28, 2026
Enterprise to Revenue
7.71x
vs Health Information Services peers
Updated Sep 28, 2026
Enterprise to EBITDA
-9.26x
vs Health Information Services peers
Updated Sep 28, 2026
Gross Margin
64.61%
vs Health Information Services peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 66.63%.Updated Sep 28, 2026
Profit Margin
-93.86%
vs Health Information Services peers
Updated Sep 28, 2026
Operating Margin
-86.03%
vs Health Information Services peers
Updated Sep 28, 2026
Return on Assets (TTM)
-24.52%
vs Health Information Services peers
Updated Sep 28, 2026
Return on Equity (TTM)
-101.22%
vs Health Information Services peers
Updated Sep 28, 2026
Revenue (TTM)
86.17MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Revenue per Share (TTM)
1.24USDUpdated Sep 28, 2026
Quarterly Revenue Growth
27.20%
vs Health Information Services peers
Updated Sep 28, 2026
Gross Profit (TTM)
57.41MUSD
vs all stocks (USD)
Updated Sep 28, 2026
EBITDA (TTM)
-71.75MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Net Income (TTM)
-80.88MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Quarterly Earnings Growth (YoY)
27.22%
vs Health Information Services peers
Updated Sep 28, 2026
Operating Cash Flow (TTM)
-39.74MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Levered Free Cash Flow (TTM)
-25.66MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 28, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Sep 28, 2026
Revenue
77.27MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
25.19MUSDFY2025 · Dec 31, 2025
Gross Profit
52.08MUSDFY2025 · Dec 31, 2025
Operating Income
-70.91MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-77.49MUSDFY2025 · Dec 31, 2025
Income Tax Expense
1.51MUSDFY2025 · Dec 31, 2025
Net Income
-79.00MUSDFY2025 · Dec 31, 2025
EBIT
-72.93MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-59.51MUSDFY2025 · Dec 31, 2025
Research & Development
34.22MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
86.07MUSDFY2025 · Dec 31, 2025
Other Operating Expenses
86.00KUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
1.87MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.55MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-1.17USDFY2025 · Dec 31, 2025
EPS (Diluted)
-1.17USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
67.54MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
67.54MSharesFY2025 · Dec 31, 2025
Operating Cash Flow
-37.23MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-37.80MUSDDerived from operating cash flow minus capital expenditure. This filing charges 9.53M of depreciation against 574K of capital expenditure, and its own free-cash-flow line reads -44.51M.FY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
70.29MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-77.49MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
9.53MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-977.00KUSDFY2025 · Dec 31, 2025
Stock-based Compensation
16.20MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
5.13MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-6.60MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
16.93MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
46.00KUSDFY2025 · Dec 31, 2025
Capital Expenditures
-574.00KUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-108.00KUSDFY2025 · Dec 31, 2025
Net Acquisitions
-1.89MUSDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.46MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
34.56MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.87MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Net Financing Cash Flow
33.78MUSDFY2025 · Dec 31, 2025
Shares Outstanding
85.13MSharesUpdated Sep 28, 2026
Float Shares
65.38MSharesUpdated Sep 28, 2026
Shares Short
1.07MSharesUpdated Sep 28, 2026
Short Ratio
1.73days
vs all stocks
Updated Sep 28, 2026
Short % of Shares Outstanding
1.33%
vs all stocks
Updated Sep 28, 2026
% Held by Insiders
6.78%
vs all stocks
Updated Sep 28, 2026
% Held by Institutions
62.26%
vs all stocks
Updated Sep 28, 2026
Total Cash (MRQ)
107.67MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Total Cash per Share (MRQ)
1.26USDUpdated Sep 28, 2026
Total Debt (MRQ)
61.83MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Total Debt to Equity (MRQ)
0.7439x
vs Health Information Services peers
Updated Sep 28, 2026
Current Ratio (MRQ)
2.69x
vs Health Information Services peers
Updated Sep 28, 2026
Book Value per Share (MRQ)
0.9760USDUpdated Sep 28, 2026
Total Assets
163.03MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
99.08MUSDFY2025 · Dec 31, 2025
Total Liabilities
115.89MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
63.95MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
65.36MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
50.53MUSDFY2025 · Dec 31, 2025
Cash
37.46MUSDFY2025 · Dec 31, 2025
Cash Equivalents
32.83MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
70.29MUSDFY2025 · Dec 31, 2025
Accounts Receivable
14.40MUSDFY2025 · Dec 31, 2025
Inventory
6.35MUSDFY2025 · Dec 31, 2025
Accounts Payable
5.32MUSDFY2025 · Dec 31, 2025
Short-term Debt
2.70MUSDFY2025 · Dec 31, 2025
Deferred Revenue
16.72MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
1.41MUSDFY2025 · Dec 31, 2025
Long-term Debt
60.32MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
876.00KUSDFY2025 · Dec 31, 2025
Common Stock (Book)
4.81MUSDFY2025 · Dec 31, 2025
Retained Earnings
-519.28MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
47.15MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
1.22MUSDFY2025 · Dec 31, 2025
52-Week Low
3.75USDUpdated Sep 28, 2026
52-Week High
8.98USDUpdated Sep 28, 2026
52-Week Change
93.00%
vs all stocks
Updated Sep 28, 2026
Beta
0.9820x
vs all stocks
Updated Sep 28, 2026
50-Day MA
7.43USDUpdated Sep 28, 2026
200-Day MA
5.59USDUpdated Sep 28, 2026
Avg 10-Day Volume
834.44KSharesUpdated Sep 28, 2026
Avg 30-Day Volume
644.91KSharesUpdated Sep 28, 2026
Diluted EPS (TTM)
-1.16USDUpdated Sep 28, 2026
Other Income / Expense
-3.90MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -93.9%, lower than 95% of its Health Information Services peers (median -3.7%)Significant